000 | 01066 a2200301 4500 | ||
---|---|---|---|
005 | 20250515224706.0 | ||
264 | 0 | _c20130320 | |
008 | 201303s 0 0 chi d | ||
022 | _a0254-6450 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Qiao-lan | |
245 | 0 | 0 |
_a[Application of multilevel models in the evaluation of bioequivalence (II).]. _h[electronic resource] |
260 |
_bZhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi _cMar 2010 |
||
300 |
_a333-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aModels, Statistical |
650 | 0 | 4 | _aMultilevel Analysis |
650 | 0 | 4 | _aRosiglitazone |
650 | 0 | 4 | _aTherapeutic Equivalency |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacokinetics |
700 | 1 | _aShen, Zhuo-zhi | |
700 | 1 | _aLi, Xiao-song | |
700 | 1 | _aChen, Feng | |
700 | 1 | _aYang, Min | |
773 | 0 |
_tZhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi _gvol. 31 _gno. 3 _gp. 333-9 |
|
999 |
_c19862291 _d19862291 |